Dr. Garnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-5288Fax+1 617-975-5665
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1974
Perelman School of Medicine at the University of PennsylvaniaClass of 1972
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
MA State Medical License 1976 - 2025
FL State Medical License 2012 - 2014
PA State Medical License 1973 - 1974- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy Start of enrollment: 2004 May 01
Publications & Presentations
PubMed
- 62 citationsRisk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surv...Ignacio F. San Francisco, Lillian Werner, Meredith M. Regan, Marc B. Garnick, Glenn J. Bubley
The Journal of Urology. 2011-02-01 - 12 citationsOral Metoclopramide and Cisplatin ChemotherapyMarc B. Garnick
Annals of Internal Medicine. 1983-07-01 - 327 citationsBiology and Management of Bladder CancerDerek Raghavan, William U. Shipley, Marc B. Garnick, Pamela J. Russell, Jerome P. Richie
The New England Journal of Medicine. 1990-04-19
Press Mentions
CAR-T Immunotherapy for Prostate Cancer?September 16th, 2024- Radiation Therapy Elevates Risks for Future CancersSeptember 9th, 2022
- New Treatment Approved for Late-Stage Prostate CancerApril 7th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
